These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19745134)

  • 1. Purposeful learning with drug repurposing.
    Toney JH; Fasick JI; Singh S; Beyrer C; Sullivan DJ
    Science; 2009 Sep; 325(5946):1339-40. PubMed ID: 19745134
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug discovery. Repurposing with a difference.
    Boguski MS; Mandl KD; Sukhatme VP
    Science; 2009 Jun; 324(5933):1394-5. PubMed ID: 19520944
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug discovery chemistry: a primer for the non-specialist.
    Jordan AM; Roughley SD
    Drug Discov Today; 2009 Aug; 14(15-16):731-44. PubMed ID: 19416759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of drug repositioning in the current pharmaceutical market.
    Tobinick EL
    Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing for neglected diseases.
    Uliana SR; Barcinski MA
    Science; 2009 Nov; 326(5955):935; author reply 935. PubMed ID: 19965498
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postmarketing surveillance studies in community pharmacies].
    Nieber K; Lehmacher W
    Med Monatsschr Pharm; 2009 Aug; 32(8):301-6. PubMed ID: 19777737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient- and physician-oriented web sites and drug surveillance: bisphosphonates and severe bone, joint, and muscle pain.
    Demonaco HJ
    Arch Intern Med; 2009 Jun; 169(12):1164-6. PubMed ID: 19546419
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety issues specific to clinical development of protein therapeutics.
    Haller CA; Cosenza ME; Sullivan JT
    Clin Pharmacol Ther; 2008 Nov; 84(5):624-7. PubMed ID: 18701885
    [No Abstract]   [Full Text] [Related]  

  • 10. Down on the "pharm": do genetically modified plants hold the key to cheaper drugs?
    Watts G
    BMJ; 2012 May; 344():e3829. PubMed ID: 22654068
    [No Abstract]   [Full Text] [Related]  

  • 11. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment].
    Gustafsson LL; Wettermark B; Kalin M; Korkmaz S; Persson ME; Almkvist H; Hjemdahl P; Julander M; Kristianson K; Ringertz B; Bergen-Dahl GT; Wilking N
    Lakartidningen; 2008 Oct 15-21; 105(42):2917-22. PubMed ID: 19025148
    [No Abstract]   [Full Text] [Related]  

  • 13. Organizing for innovation: towards successful translational research.
    West W; Nightingale P
    Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informatics and computation for drug discovery - specialist or mainstream tools?
    Gund P; Maliski E; Brown F
    Curr Opin Drug Discov Devel; 2009 May; 12(3):337-8. PubMed ID: 19396734
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people.
    Nishtala PS; Fois RA; McLachlan AJ; Bell JS; Kelly PJ; Chen TF
    J Clin Pharmacol; 2009 Oct; 49(10):1176-84. PubMed ID: 19783711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacovigilance in India: how safe are the new drugs? How sure are we?
    Joshi SR; Sapatnekar SM
    J Assoc Physicians India; 2008 Dec; 56():933-4. PubMed ID: 19322970
    [No Abstract]   [Full Text] [Related]  

  • 17. Futurescapes: expectations in Europe for relative effectiveness evidence for drugs in 2020.
    Towse A; Garau M; Mohr P; Messner DA
    J Comp Eff Res; 2015 Aug; 4(4):401-18. PubMed ID: 25740283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surveillance studies criticized. A marketing effort for expensive drugs? "Not throwing the baby out with the bath water" (interview by Dr. Beate Schumacher)].
    Selbmann HK
    MMW Fortschr Med; 2009 Aug; 151(34-35):6. PubMed ID: 19771776
    [No Abstract]   [Full Text] [Related]  

  • 19. Do biologically relevant compounds have more chance to be drugs?
    Kong DX; Ren W; Lü W; Zhang HY
    J Chem Inf Model; 2009 Oct; 49(10):2376-81. PubMed ID: 19852515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["There are clear criteria for product surveillance studies"].
    Throm S
    MMW Fortschr Med; 2009 Aug; 151(34-35):7. PubMed ID: 19771777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.